Position in NTRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$429,433
New position
Shares Held
1,582
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#560
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $10,533,681 across 13 Diagnostics & Research names. NTRA ranks #10 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,217 | $2,615,595 | |
| 2 | DHR |
Danaher Corp /De/
|
7,472 | $1,423,266 | |
| 3 | ILMN |
Illumina, Inc.
|
5,962 | $1,048,298 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,776 | $934,957 | |
| 5 | DGX |
Quest Diagnostics Inc
|
3,796 | $804,562 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
3,515 | $679,168 | |
| 7 | FLGT |
Fulgent Genetics, Inc.
|
28,824 | $591,468 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
1,109 | $587,315 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $429,433 | 1,582 | Shares | Defined | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||